Novaleum | €1M | 🌡️ Climate Tech

Lyon-based Novaleum raised €1 million in a Pre-Seed round from business angels to industrialise its technology for converting fatty waste from restaurant grease traps and food processing residues into biofuels and biogas. Spun out of three Lyon research labs (ILM, ICBMS, and IUT Lyon 1's chemistry department), the company uses a patented continuous thermomechanical separation process; each modular unit can process 1,000 tonnes of fatty waste per year and yield 100 tonnes of advanced biofuels.

Ellipse Bikes | €1.5M | 🛣️ Transportation

Based in Troyes, Ellipse Bikes raised €1.5 million in its first equity funding round with SideAngels, Bpifrance, and Caisse d'Épargne, topped up by a Crowdcube crowdfunding campaign. The company makes French-assembled urban bikes for the B2B market, pairing the bike itself with leasing, insurance, and employer fiscal support tools so independent cycle shops can offer vélo de fonction packages to local businesses without needing complex infrastructure of their own.

Cigno | €1.5M | 🗣️ AI Agents

Cigno raised €1.5 million from sector business angels, including former senior executives from Swissquote, DLA Piper, and Reyl Intesa Sanpaolo, to build AI infrastructure purpose-built for management consulting firms. The entire platform runs on Scaleway with a fleet of 80 LLMs including European open-weight models so client knowledge bases never leave the firm’s environment. Pilots are currently live in France, the UK, and Switzerland.

Mediads | €3M | 📢 MarTech

Paris-based Mediads raised €3 million in a Seed round led by Seventure Partners with 404 Ventures and business angels. Founded in 2022 by Alfred Cardinal and Stéphane Labrouche, the company lets brands run social ad campaigns through the accounts of 250+ premium media publishers like Figaro, Brut, Euronews, and Time Out with clients reporting up to +150% performance gains on identical campaigns.

Leadbay | €3.7M | ↔️ B2B Software

YC-backed Leadbay raised €3.7 million ($4.3 million) in a Seed round with Rebel Ventures, Roosh Ventures, and a clutch of angel investors from Deel, Gusto, and Pennylane. The startup builds AI-powered sales prospecting for industries where most businesses have no digital footprint like construction, hospitality, retail, and local services. These are the same segments that tools like LinkedIn Sales Navigator and Apollo simply can't see because there's company website or LinkedIn profile to find. The round will fund further US go-to-market expansion in San Francisco and a research partnership with Sorbonne University to improve the company’s underlying AI inference models.

Dealinka | €6.5M | ♻️ Circular Economy

Founded in Valenciennes in 2023, Dealinka raised €6.5 million in a growth round led by Re-Sources. The company manages the full operational, logistical, and regulatory complexity of redistributing large volumes of unsold non-food goods from major corporations to charities. Three years in, the company has reached 64 employees, €5.1 million in revenue, 45,000 pallets processed, and €31 million in donations redistributed. The round will fund further European expansion and continued product development.

Lupin & Holmes | €5M | 🛡️ Cybersecurity

Lupin & Holmes raised €5 million ($5.9 million) in a Pre-Seed round co-led by 20VC and Seedcamp with participation from Purple Fund, Kima Ventures, and founders of Wiz, Hugging Face, and GitGuardian. The company, named after popular fictional characters Arsène Lupin and Sherlock Holmes, was founded by 24-year-old Roni Carta. That’s the same Roni Carti who earned nearly $800,000 in bug bounty rewards from Google, Amazon, Netflix, and PayPal before turning 23. Carta is putting his skills to further use on Lupin & Holmes’ platform Depi, which maps software supply chain attack paths and detects threats before they create problems. Depi gained early attention for spotting a worm targeting Mistral AI 25 days before it struck and already counts several Fortune 500 clients amongst its user base, including Ledger.

Virtual Browser | €6M | 🛡️ Cybersecurity

Virtual Browser raised €6 million in a Seed round from GO Capital, BNP Paribas Développement, Auriga Cyber Ventures, and Bpifrance to expand its remote browser isolation platform across Europe. Their product runs browsing sessions server-side and streams a pixel-perfect view to the user's device to prevent malware and phishing attacks. Already deployed to 150,000 users across a client list that includes Thales, Dassault, and the French Ministry of Foreign Affairs, the company is now building out mobile apps for iOS and Android and pursuing additional European security certifications.

Mister IA | €10M | 🤖 AI

Mister IA raised €10 million in a growth round led by Momentum Invest with 199 Ventures, with founders Vincent and Martin Pavanello retaining majority. The AI consulting firm deploys AI agents directly into client workflows (think forward-deployed engineers rather than slide decks) for enterprises like Vinci, Mercedes, Clarins, Thales, and the French Army.

Otrera | €10M | ☢️ Nuclear Energy

Aix-en-Provence-based Otrera raised €10 million in a strategic investment round with EDF, Groupe ADF and others plus €7.5 million in non-dilutive public funding from France 2030. The company is building a fourth-generation sodium-cooled small modular reactor (SMR) of 110 MWe. This is the same technology France has tried and abandoned three times, which is why the company's pitch is essentially "the fourth time is the charm." The round funds a detailed pre-project phase and dedicated testing infrastructure ahead of a planned factory opening in Cherbourg and future €40 million third round at the end of the year.

Sonomind | €20M | 🩺 Medtech

Paris-based Sonomind raised €20 million in a Series A round led by Critical Path Ventures with participation from Bpifrance's French Tech Seed and Deep Tech 2030 programs. The company has built a non-invasive brain stimulation device for treatment-resistant depression without requiring an implant. Picture a helmet that uses low-intensity focused ultrasound and a custom acoustic lens to hit deep brain structures with surgical precision minus the surgery. Early clinical results published in Brain Stimulation showed a 60%+ reduction in symptom severity after five daily sessions with no significant side effects. The funding will go toward randomized multicenter trials targeting regulatory approval by 2029.

Prelude | €17.23M | 🛡️ Cybersecurity

Paris-based Prelude raised €17.2 million ($20 million) in a Series A round led by 20VC with Singular, Seedcamp, Deel, and FDJ UNITED Ventures. The company builds the trust infrastructure behind login and signup flows with an aim to replace CAPTCHAs and SMS codes with AI signals drawn from telecom data, device intelligence, and behavioral patterns across 230 countries. Revenue and customers each grew 6x in the past year and clients like BeReal, Sunday, Suno, and Voodoo are already using Prelude to distinguish real users from bots at scale.

Dust | €34.5M | 🗣️ AI Agents

Dust, the enterprise AI platform, has raised €34.5 million ($40 million) in a Series B round co-led by Sequoia and Abstract with Snowflake and Datadog also participating. The company has created a portal that lets enterprises deploy and manage AI agents with shared memory, business-specific context, and secure access to shared projects in the same way human employees share a Notion or a Slack. Founded by two ex-Stripe engineers, including one who spent three years at OpenAI, Dust has over 3,000 organizations on their platform with more than 300,000 agents deployed. The new round will go toward developing agents that learn and improve autonomously along with further improved enterprise governance tooling.

UroMems | €51.7M | 🩺 Medtech

Based in Grenoble, UroMems raised €51.7 million ($60 million) in a strategic investment round backed by US-based Ajax Health Fund I to support pivotal clinical trials and market preparation for its UroActive smart implant. The company makes an automated robotic implant that treats urinary incontinence by using MEMS-based sensors and algorithms to adapt to the patient's activity level in real time. The funding will carry UroMems through the SOPHIA2 trial running across 21 investigational sites in the US and France ahead of regulatory submissions in both markets.